Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133.
Article PubMed PubMed Central Google Scholar
Ali SZ, Baloch ZW, Cochand-Priollet B, et al. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2023;33(9):1039–44.
Carty SE, Ohori NP, Hilko DA, et al. The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules). Ann Surg. 2020;272(4):621–7.
Roth MY, Witt RL, Steward DL. Molecular testing for thyroid nodules: Review and current state. Cancer. 2018;124(5):888–98.
Yang J, Zhang Y, Li X, Zhao Y, Han X, Chen G, et al. Efficacy and safety of ultrasound-guided microwave ablation versus surgical resection for bethesda category IV thyroid nodules: a retrospective comparative study. Front Endocrinol (Lausanne). 2022;13:924993.
Livhits MJ, Zhu CY, Kuo EJ, et al. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial. JAMA Oncol. 2021;7(1):70–7.
Papini E, Monpeyssen H, Frasoldati A, Hegedüs L. 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules. Eur Thyroid J. 2020;9(4):172–185.
Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013;16(4):192–200.
Article PubMed PubMed Central Google Scholar
Angelos P, Baek JH, Brumund KT, et al. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck. 2022;44(3):633–60.
Kim HJ, Cho SJ, Baek JH, Suh CH. Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2021;31(2):605–15.
Cui T, Jin C, Jiao D, Teng D, Sui G. Safety and efficacy of microwave ablation for benign thyroid nodules and papillary thyroid microcarcinomas: A systematic review and meta-analysis. Eur J Radiol. 2019;118:58–64.
Yan L, Zhang M, Song Q, Luo Y. Ultrasound-Guided-Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients. Thyroid. 2021;31(11):1662–72.
Article CAS PubMed Google Scholar
Kim JH, Yoo WS, Park YJ, et al. Efficacy and Safety of Radiofrequency Ablation for Treatment of Locally Recurrent Thyroid Cancers Smaller than 2 cm. Radiology. 2015;276(3):909–18.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Article PubMed PubMed Central Google Scholar
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.
Lin WC, Tung YC, Chang YH, Luo SD, Chiang PL, Huang SC, et al. Radiofrequency ablation for treatment of thyroid follicular neoplasm with low SUV in PET/CT study. Int J Hyperthermia. 2021;38(1):963–9.
Li X, Lan Y, Li N, Yan L, Xiao J, Zhang M, Luo Y. Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study. Front Endocrinol (Lausanne). 2021;12:674970.
Article PubMed PubMed Central Google Scholar
Ha SM, Sung JY, Baek JH, Na DG, Kim JH, Yoo H, Lee D, Whan Choi D. Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes. Int J Hyperth. 2017;33(8):931–7.
Dong Y, Zhan W, Zhou J, Li N, Liu Z, Xia S, Ni X, Liu J, Zhang J, Xu S, Yang Z, Hua Q. Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules. Eur Radiol. 2024;34(3):1597–604.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264–72.
Barrows CE, Belle JM, Fleishman A, Lubitz CC, James BC. Financial burden of thyroid cancer in the United States: An estimate of economic and psychological hardship among thyroid cancer survivors. Surgery. 2020;167(2):378–84.
Jensen CBa, Pitt. Susan C.b,c. Patient perception of receiving a thyroid cancer diagnosis. Curr Opin Endocrinol Diabetes Obes. October 2021;28(5):533–9.
Bible KC, Kebebew E, Brierley J et al. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2021;31(3):337–386.
Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. J Am Soc Cytopathol. 2017 Nov-Dec;6(6):217–22.
Scappaticcio L, Trimboli P, Iorio S, et al. Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS. Front Endocrinol (Lausanne). 2022;13:1001728.
Yaprak Bayrak B, Eruyar AT. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology. BMC Endocr Disord. 2020;20(1):48.
Article PubMed PubMed Central Google Scholar
Steward DL, Carty SE, Sippel RS, et al. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019;5(2):204–12.
Kim NE, Raghunathan RS, Hughes EG, et al. Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3. J Clin Endocrinol Metab. 2023;108(9):e698–703.
Article PubMed PubMed Central Google Scholar
Scappaticcio L, Di Martino N, Caruso P, et al. The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules. Horm (Athens). 2024 Jun;17. https://doi.org/10.1007/s42000-024-00573-8.
Tufano RP, Pace-Asciak P, Russell JO, et al. Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now. Front Endocrinol (Lausanne). 2021;12:698689.
Issa PP, Omar M, Issa CP, et al. Radiofrequency Ablation of Indeterminate Thyroid Nodules: The First North American Comparative Analysis. Int J Mol Sci. 2022;23(19):11493.
Article CAS PubMed PubMed Central Google Scholar
Shuai-nan SHI, Ling-xiao LIU, Dan ZUO, Qi ZHANG, Yi-jie QIU, Yi DONG. WANG Wen-ping. Application of contrast enhanced ultrasound in microwave ablation of thyroid nodules[J]. Fudan Univ J Med Sci. 2022;49(1):10–5.
Dobrinja C, Bernardi S, Fabris B, et al. Surgical and Pathological Changes after Radiofrequency Ablation of Thyroid Nodules. Int J Endocrinol. 2015;2015:576576.
留言 (0)